vs

Side-by-side financial comparison of SOLESENCE, INC. (SLSN) and SWK Holdings Corp (SWKH). Click either name above to swap in a different company.

SOLESENCE, INC. is the larger business by last-quarter revenue ($12.5M vs $8.7M, roughly 1.4× SWK Holdings Corp). On growth, SOLESENCE, INC. posted the faster year-over-year revenue change (-0.7% vs -29.7%). Over the past eight quarters, SOLESENCE, INC.'s revenue compounded faster (12.5% CAGR vs -12.5%).

SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.

SLSN vs SWKH — Head-to-Head

Bigger by revenue
SLSN
SLSN
1.4× larger
SLSN
$12.5M
$8.7M
SWKH
Growing faster (revenue YoY)
SLSN
SLSN
+29.0% gap
SLSN
-0.7%
-29.7%
SWKH
Faster 2-yr revenue CAGR
SLSN
SLSN
Annualised
SLSN
12.5%
-12.5%
SWKH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SLSN
SLSN
SWKH
SWKH
Revenue
$12.5M
$8.7M
Net Profit
$163.0K
$-19.4M
Gross Margin
27.5%
Operating Margin
1.5%
9.9%
Net Margin
1.3%
Revenue YoY
-0.7%
-29.7%
Net Profit YoY
129.2%
-430.2%
EPS (diluted)
$0.00
$-1.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLSN
SLSN
SWKH
SWKH
Q4 25
$12.5M
$8.7M
Q3 25
$14.6M
$10.9M
Q2 25
$20.4M
$10.1M
Q1 25
$14.6M
$11.8M
Q4 24
$12.6M
$12.4M
Q3 24
$16.9M
$10.4M
Q2 24
$13.0M
$10.8M
Q1 24
$9.9M
$11.4M
Net Profit
SLSN
SLSN
SWKH
SWKH
Q4 25
$163.0K
$-19.4M
Q3 25
$-1.1M
$8.8M
Q2 25
$2.7M
$3.5M
Q1 25
$80.0K
$4.5M
Q4 24
$-559.0K
$5.9M
Q3 24
$3.0M
$3.5M
Q2 24
$856.0K
$3.7M
Q1 24
$893.0K
$468.0K
Gross Margin
SLSN
SLSN
SWKH
SWKH
Q4 25
27.5%
Q3 25
23.1%
Q2 25
28.9%
Q1 25
23.1%
Q4 24
22.0%
Q3 24
36.2%
Q2 24
28.7%
Q1 24
36.3%
Operating Margin
SLSN
SLSN
SWKH
SWKH
Q4 25
1.5%
9.9%
Q3 25
-5.4%
61.3%
Q2 25
9.4%
46.1%
Q1 25
1.8%
68.6%
Q4 24
-1.8%
44.7%
Q3 24
19.0%
39.2%
Q2 24
8.0%
8.3%
Q1 24
11.3%
9.5%
Net Margin
SLSN
SLSN
SWKH
SWKH
Q4 25
1.3%
Q3 25
-7.7%
80.7%
Q2 25
13.1%
35.2%
Q1 25
0.5%
38.4%
Q4 24
-4.4%
47.5%
Q3 24
18.1%
33.3%
Q2 24
6.6%
33.9%
Q1 24
9.0%
4.1%
EPS (diluted)
SLSN
SLSN
SWKH
SWKH
Q4 25
$0.00
$-1.59
Q3 25
$-0.02
$0.72
Q2 25
$0.04
$0.29
Q1 25
$0.00
$0.37
Q4 24
$0.00
$0.47
Q3 24
$0.04
$0.28
Q2 24
$0.01
$0.30
Q1 24
$0.02
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLSN
SLSN
SWKH
SWKH
Cash + ST InvestmentsLiquidity on hand
$1.3M
$42.8M
Total DebtLower is stronger
$33.0M
Stockholders' EquityBook value
$17.6M
$235.1M
Total Assets
$50.1M
$272.4M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLSN
SLSN
SWKH
SWKH
Q4 25
$1.3M
$42.8M
Q3 25
$429.0K
$10.2M
Q2 25
$4.1M
$8.0M
Q1 25
$1.8M
$29.8M
Q4 24
$1.4M
$5.9M
Q3 24
$2.9M
$17.2M
Q2 24
$2.4M
$5.5M
Q1 24
$2.0M
$5.5M
Total Debt
SLSN
SLSN
SWKH
SWKH
Q4 25
$33.0M
Q3 25
$33.0M
Q2 25
$33.0M
Q1 25
$33.0M
Q4 24
$33.0M
Q3 24
$33.0M
Q2 24
$33.0M
Q1 24
$33.0M
Stockholders' Equity
SLSN
SLSN
SWKH
SWKH
Q4 25
$17.6M
$235.1M
Q3 25
$17.2M
$254.2M
Q2 25
$18.2M
$246.5M
Q1 25
$15.2M
$292.7M
Q4 24
$14.9M
$288.7M
Q3 24
$15.2M
$283.4M
Q2 24
$11.9M
$282.8M
Q1 24
$5.0M
$279.9M
Total Assets
SLSN
SLSN
SWKH
SWKH
Q4 25
$50.1M
$272.4M
Q3 25
$54.0M
$289.4M
Q2 25
$60.0M
$285.7M
Q1 25
$57.0M
$331.3M
Q4 24
$50.0M
$332.2M
Q3 24
$48.0M
$321.3M
Q2 24
$40.8M
$321.0M
Q1 24
$38.5M
$322.0M
Debt / Equity
SLSN
SLSN
SWKH
SWKH
Q4 25
0.14×
Q3 25
0.13×
Q2 25
0.13×
Q1 25
0.11×
Q4 24
0.11×
Q3 24
0.12×
Q2 24
0.12×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLSN
SLSN
SWKH
SWKH
Operating Cash FlowLast quarter
$1.8M
$27.3M
Free Cash FlowOCF − Capex
$26.8M
FCF MarginFCF / Revenue
308.1%
Capex IntensityCapex / Revenue
5.9%
Cash ConversionOCF / Net Profit
11.16×
TTM Free Cash FlowTrailing 4 quarters
$43.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLSN
SLSN
SWKH
SWKH
Q4 25
$1.8M
$27.3M
Q3 25
$-2.5M
$906.0K
Q2 25
$-654.0K
$7.8M
Q1 25
$-7.2M
$8.3M
Q4 24
$2.2M
$23.0M
Q3 24
$4.2M
$6.3M
Q2 24
$-565.0K
$5.4M
Q1 24
$-3.9M
$4.4M
Free Cash Flow
SLSN
SLSN
SWKH
SWKH
Q4 25
$26.8M
Q3 25
$557.0K
Q2 25
$7.7M
Q1 25
$8.2M
Q4 24
$-404.0K
$22.9M
Q3 24
$2.8M
$6.3M
Q2 24
$-1.0M
$5.4M
Q1 24
$-3.9M
FCF Margin
SLSN
SLSN
SWKH
SWKH
Q4 25
308.1%
Q3 25
5.1%
Q2 25
77.0%
Q1 25
69.1%
Q4 24
-3.2%
185.3%
Q3 24
16.6%
60.4%
Q2 24
-8.0%
49.7%
Q1 24
-39.9%
Capex Intensity
SLSN
SLSN
SWKH
SWKH
Q4 25
5.9%
Q3 25
3.2%
Q2 25
0.6%
Q1 25
0.8%
Q4 24
20.6%
1.1%
Q3 24
8.3%
0.3%
Q2 24
3.7%
0.2%
Q1 24
0.9%
0.0%
Cash Conversion
SLSN
SLSN
SWKH
SWKH
Q4 25
11.16×
Q3 25
0.10×
Q2 25
-0.25×
2.21×
Q1 25
-90.26×
1.82×
Q4 24
3.93×
Q3 24
1.38×
1.82×
Q2 24
-0.66×
1.47×
Q1 24
-4.32×
9.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SLSN
SLSN

Segment breakdown not available.

SWKH
SWKH

Finance Receivables Segment$8.4M96%
Other$329.0K4%

Related Comparisons